Halia Therapeutics to Participate in Jefferies 2026 Global Healthcare Conference
LEHI, Utah, May 28, 2026 /PRNewswire/ -- Halia Therapeutics, Inc., The Genetic Resilience Company™, a clinical-stage biopharmaceutical company advancing first-in-class inflammation therapies anchored in protective human genetics, today announced that the Company will participate in the...
LEHI, Utah, May 28, 2026 /PRNewswire/ -- Halia Therapeutics, Inc., The Genetic Resilience Company™, a clinical-stage biopharmaceutical company advancing first-in-class inflammation therapies anchored in protective human genetics, today announced that the Company will participate in the...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.